.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Argus Health
Mallinckrodt
Dow
Fish and Richardson
Merck
McKinsey
Baxter
Harvard Business School
Johnson and Johnson

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074151

« Back to Dashboard

NDA 074151 describes CIMETIDINE, which is a drug marketed by Apotex, Chartwell Molecules, Contract Pharmacal, Cycle Pharms Ltd, Dava Pharms Inc, Ivax Sub Teva Pharms, L Perrigo Co, Mylan, Perrigo, Pliva, Sandoz, Sandoz Inc, Teva, Upsher-smith Labs, Watson Labs Inc, Watson Labs Teva, Hospira, Luitpold, Teva Parenteral, Vintage Pharms Llc, Ani Pharms Inc, Apotex Inc, G And W Labs Inc, Hi Tech Pharma, Pharm Assoc, and Wockhardt, and is included in fifty NDAs. It is available from twenty-seven suppliers. Additional details are available on the CIMETIDINE profile page.

The generic ingredient in CIMETIDINE is cimetidine hydrochloride. There are twenty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cimetidine hydrochloride profile page.

Summary for 074151

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074151

Suppliers and Packaging for NDA: 074151

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CIMETIDINE cimetidine TABLET;ORAL 074151 ANDA Teva Pharmaceuticals USA Inc 0093-8192 0093-8192-05 500 TABLET, FILM COATED in 1 BOTTLE (0093-8192-05)
CIMETIDINE cimetidine TABLET;ORAL 074151 ANDA Teva Pharmaceuticals USA Inc 0093-8192 0093-8192-01 100 TABLET, FILM COATED in 1 BOTTLE (0093-8192-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:May 17, 1994TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength300MG
Approval Date:May 17, 1994TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength400MG
Approval Date:May 17, 1994TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Fuji
Colorcon
Chinese Patent Office
Boehringer Ingelheim
Julphar
Cerilliant
Merck
Queensland Health
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot